Yanxia Liu

Also affiliated with WuXi AppTec (China), Xi'an Technological University, Raptamer Discovery Group (United States), First Hospital of Shijiazhuang, Stanford University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro”.

Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro

Nature Communications(2022)10.1038/s41467-022-30546-7

N/A

0DataRank · unranked

53 citations

Yanxia Liu, Xammy Nguyenla, Timothy R. Abbott, Mengting Han, Yan‐Yu Zhu +23 more

Statins improve endothelial function via suppression of epigenetic-driven EndMT

Nature Cardiovascular Research(2023)10.1038/s44161-023-00267-1

N/A

0DataRank · unranked

82 citations

Mengcheng Shen, Wilson Lek Wen Tan, Ian Y. Chen, Yu Liu, Xuan Yu +11 more

Identification of replicative aging and inflammatory aging signatures via whole-genome CRISPRi screens

Genome biology(2025)10.1186/s13059-025-03683-7

N/A

0DataRank · unranked

5 citations

Xiang Zhu, Yanxia Liu, Dehua Zhao, Bing Yu, Zheng Wei +3 more